GENEPOSSIBILITIES.COM

Serial Number 97232135
602

Registration Progress

Application Filed
Jan 21, 2022
Under Examination
Jan 10, 2023
Approved for Publication
Nov 15, 2022
Published for Opposition
Nov 15, 2022
Registered

Basic Information

Serial Number
97232135
Filing Date
January 21, 2022
Published for Opposition
November 15, 2022
Abandonment Date
June 30, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 17, 2023
Classes
042 044

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
50 Northern Avenue
Boston, MA 02210

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Boston, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Timothy H. Hiebert
USPTO Deadlines 4 active 4 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Dec 15, 2022 935 days overdue Medium Until Jan 15, 2023
OFFICE ACTION
Non-Final Action E-Mailed
GNRT Jun 29, 2023 739 days overdue Critical Until Sep 29, 2023
OFFICE ACTION
Non-Final Action Mailed
CNRT Jun 29, 2023 739 days overdue Critical Until Sep 29, 2023
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Jul 10, 2023 728 days overdue High Until Jan 10, 2024

Application History

24 events
Date Code Type Description
Jul 17, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 17, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 17, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 29, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN
Mar 29, 2023 GNRT O NON-FINAL ACTION E-MAILED
Mar 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 13, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jan 13, 2023 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 13, 2023 IUAF S USE AMENDMENT FILED
Jan 10, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 15, 2022 PUBO A PUBLISHED FOR OPPOSITION
Nov 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 7, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 15, 2022 GNRT F NON-FINAL ACTION E-MAILED
Aug 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2022 DOCK D ASSIGNED TO EXAMINER
Jan 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of gene editing
First Use Anywhere: May 5, 2022
First Use in Commerce: May 5, 2022
Class 044
Providing medical and healthcare information in the field of gene editing technology; Providing medical and healthcare information in the field of gene editing technology to health care professionals, to persons having genetic diseases, and to their caregivers
First Use Anywhere: May 5, 2022
First Use in Commerce: May 5, 2022

Additional Information

Pseudo Mark
GENE POSSIBILITIES

Classification

International Classes
042 044